Abstract
A series of hydroxamate based HDAC inhibitors containing a phenylisoxazole as the CAP group has been synthesized using nitrile oxide cycloaddition chemistry. An HDAC6 selective inhibitor having a potency of ∼2 picomolar was identified. Some of the compounds were examined for their ability to block pancreatic cancer cell growth and found to be about 10-fold more potent than SAHA. This research provides valuable, new molecular probes for use in exploring HDAC biology.
Original language | English (US) |
---|---|
Pages (from-to) | 4370-4373 |
Number of pages | 4 |
Journal | Journal of medicinal chemistry |
Volume | 51 |
Issue number | 15 |
DOIs | |
State | Published - Aug 14 2008 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery